SuspendedNCT05567848
Accelerated TMS in Psychosis
Device studyAges 18–65United StatesSchizophrenia
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- BostonSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 29, 2022
- Recruitment status
- Suspended
- Enrollment listed in the registry
- 20
- Sponsor
- Beth Israel Deaconess Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Device
- Intervention type
- Device
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05567848
- Official title
Show the full official title
Accelerated Transcranial Magnetic Stimulation in Psychotic Disorders
Recruitment & locations
SuspendedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Beth Israel Deaconess Medical Center, a hospital or academic medical center.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as suspended.
